NHS Logo
  • Home
  • About Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter
  • Contact Us

Stories by Paul Craven

PreventionTherapeutic Patients with both COVID-19 and flu are at much greater risk of severe disease and death

PreventionTherapeutic Patients with both COVID-19 and flu are at much greater risk of severe disease and death

Published on 5th April 2022
Informatics Approaches Patients with severe or poorly-controlled asthma are at greater risk of hospitalisation with COVID-19

Informatics Approaches Patients with severe or poorly-controlled asthma are at greater risk of hospitalisation with COVID-19

Published on 5th April 2022
First in HumanPartnershipVideo COVID-19 human challenge study – first results

First in HumanPartnershipVideo COVID-19 human challenge study – first results

Published on 5th April 2022
EventInnovationPartnership Imperial Enterprise Week: seven inventions and the inventors behind them

EventInnovationPartnership Imperial Enterprise Week: seven inventions and the inventors behind them

Published on 21st March 2018

Therapeutic Imperial receives approval to begin the world’s first trial of MDMA to treat alcohol addiction

Published on 27th October 2017
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Funding Call NIHR Imperial BRC Surgery & Cancer Theme Joint Pilot Project Call with Ovarian Cancer Action and Brain Tumour Research
  • Treatment Flexible hepatitis C treatments could pave the way for elimination
  • Training NIHR Imperial BRC pre-application support funds
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre